Research and Development

NICE has approved Eisai’s Halaven (eribulin) for routine treatment of sufferers of locally advanced or metastatic breast cancer that has …

It has come to light that, over a 20 year period, Eli Lily has increased the price of its diabetes …

MSD, known as Merck in North America, has published results of a Phase I trial of verubecestat. The drug is …

The US Food and Drugs Administration (FDA) has issued a Chinese firm with a warning letter after claims it intentionally …

Gilead Sciences followed Pfizer in discreetly dropping a drug alongside its third quarter profit reports. The drug in question, for …

Multi Packaging Solutions (“MPS”)(NYSE: MPSX),  a global market leader in healthcare, spirits, confectionery and media packaging, has been voted the …

Biotherapeutic and research reagent developer Avacta has announced it will collaborate with New York’s Memorial Sloan Kettering Cancer Center (MSK, …

Nimbus Therapeutics only signed a deal with Gilead Sciences back in April of this year and yet have already received …

IBM is set to join forces with Celgene to develop a new drug safety evaluation platform, it has emerged. Running …

Valeant is rumoured to be looking into selling its Salix drugs business to Takeda Pharmaceutical, with figures floated of a …

Pfizer announced the news that it would no longer be developing an experimental cholesterol lowering drug. The drug had been …

Takeda UK have appointed Marc Weeks to the newly created role of digital lead. The creation of the role comes as …

The awards ceremony, held at The Seven Dials Club, Covent Garden, London on Friday 7 October, drew leading event and …

Japanese pharma firm Astellas is set to bolster its oncology business with the acquisition of Ganymed Pharmaceuticals in a deal …

Novartis has named Cynthia Chiaramitara as managing director of its plant in Grimsby, UK. She will take on the role …